Insider Transactions in Q1 2025 at An2 Therapeutics, Inc. (ANTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2025
|
Sanjay Chanda Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,957
-9.02%
|
$2,957
$1.34 P/Share
|
|
Jan 03
2025
|
Lucy Day Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,957
-8.3%
|
$2,957
$1.34 P/Share
|
|
Jan 03
2025
|
Joshua M Eizen |
SELL
Open market or private sale
|
Direct |
9,663
-7.65%
|
$9,663
$1.34 P/Share
|
|
Jan 03
2025
|
Stephen David Prior Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,029
-5.74%
|
$2,029
$1.34 P/Share
|